rins, including ceftazidime, cefepime, and cefotaxime. 12 
Objectives
The aim of this study was to determine the ESBL positive blood E. coli strains and the prevalence of bla CTX-M , bla SHV , and bla TEM types among ESBL positive blood isolates among 3 military hospitals in Tehran, Iran.
Patients and Methods

Bacterial Isolates
Twenty-three E. coli blood isolates were collected during 2015-2016, from 3 hospitals of Tehran, Iran. These isolates were obtained from the patients 2-23 years of age. Fourteen patients were female (mean age of 14.62) and 9 were male (mean age of 12.33). The isolates were identified by both confirmatory biochemical and molecular tests advised for E. coli.
Susceptibility Tests and Detection of ESBLs
Susceptibility testing was performed using the disk diffusion method as per the guidelines of Clinical and Laboratory Standards Institute (CLSI). Seventeen antimicrobial disks were used as indicated in Table 1 .
The standard ATCC25922 E. coli was used as the quality control of antimicrobial susceptibil ity testing. The ESBL phenotype determination was done using combined disk and synergy test methods employing cefotaxime and ceftazidime with and without clavulanic acid disk. The MICs of blood isolates were determined using broth microdilution method against ceftazidime in the range of 0.25-128 ug/mL (CLSI 2014). Isolates with MIC ≥1 were further tested for ESBL production in addition to ceftazidime resistant strains.
DNA Extraction
Total DNA was isolated with the boiling Method. Briefly, 200 µL of bacterial suspension was prepared in distilled water. After boiling in 95°C for 10 minutes, the centrifugation of tubes was performed and the supernatant was preserved at -20°C for later use.
Amplification of ESBL Genes
The Polymerase chain reaction (PCR) detection of CTX-M, SHV, and TEM ESBLs was done with the specific primers shown in Table 2 .
Statistical Analysis
The relations were compared by t test using SPSS version 20.0. The value of P < 0.05 was considered to be significant.
Results
The Susceptibility Testing and ESBL Production
The susceptibility testing profile between ESBL positive and negative blood strains is depicted in Table 3 .
In the broth microdilution procedure, 21 (92.7%) isolates showed MIC ≥1, and also in the combined disk test, 19 (80.1% of all) isolates were ESBL producers. On the other hand, there was a correlation between ceftazidime resistance and MIC results for ESBL production. The results of ceftazidime MIC confirmed the disk diffusion for guidance in the phenotypic production of ESBL by the isolates. 
Genotypic Detection of ESBL Enzymes
The prevalence of bla CTX-M1 , bla SHV , and bla TEM genes among ESBL producing isolates was 26% (n = 6), 8% (n = 2) and 0%, respectively ( Figure 1 ). The bla CTXM1 and bla SHV genes were associated with higher MIC against ceftazidime. The relationship among the MIC, characteristics of isolates, and presence of beta-lactamase genes for 10 adopted isolates is indicated in Table 4 .
Discussion
In the current study, the level of ESBL production and MDR phenotype among E. coli blood isolates was high. Analysis of susceptibility of the strains to antibiotics demonstrated that among beta-lactam classes, the most effective drugs were meropenem (67%) and piperacillin (85%). Most patients were aged between 2-22 years old. In addition, among non-beta-lactam antibiotics, amikacin exhibited the highest activity against the isolates (63%). Similar to these results, in some previous studies conducted in Tehran and other areas of Iran, a high rate of ESBL among Enterobacteriaceae was revealed. [13] [14] [15] Recent publications have uncovered the predominant interference of bla CTXM1 in ESBL positive isolates all over the world. In the present study, bla CTXM1 group was accounted for 26% of blood ESBL production. This was the first study detecting the ESBL production in blood E. coli as well as molecular detection of related beta-lactamases in 3 military hospitals of Tehran. Similarly, results from previous molecular studies have demonstrated that bla CTX-M1 is endemic and is present among ST131 or non ST131 clones in healthcare and community settings. [16] [17] [18] [19] The bla CTXM1 was detected in the range of 4-32 ug/mL ceftazidime, although higher MIC was associated with MDR and presence of both bla CTXM1 and bla SHV genes. It has been demonstrated that bla CTXM1/14 and bla CTXM-15 genes cause high level of resistance to cefepime/ceftriaxone and ceftazidime, respectively. 12 On the other, despite most of these studies, blood isolates exhibited a low frequency of ESBL encoding genes, supposed that other beta-lactamase classes interfere in the resistance to third generation cephalosporins. Our results were different from those of a study by Mohajeri et al in the West of Iran in which bla CTXM1 , bla SHV , and bla TEM were detected in 93.3%, 68.3%, and 43.2% of isolates, respectively. 20 In another study by Mehrgan et al, of 130 isolates producing ESBL, 22 (16.3%) were bla CTXM type positive. In this study, 2 blood isolates harbored both bla CTX-M1 and bla SHV types and none of them could amplify bla TEM gene. Moreover, this study showed a correlation between higher MIC and co-resistance to multiple antibiotics, except for ciprofloxacin. The MIC, ESBL phenotype, and related genes were not significantly in relation with the age or genus of patients (P = 0.14 and 0.31, respectively).
Although the prevalence of MDR rate and ESBL production were high, bla genes were not highly detected. The isolates with higher MIC amplified both bla CTXM-I and bla SHV type beta-lactamases. Ceftazidime MIC was in accordance with the disk resistance for detecting phenotypic ESBL production. There may be multiple mechanisms for resistance to the third generation cephalosporin drugs.
